stock market today news

Bob Doll Explains How Stocks Could Be Derailed

Mercer Bullard: Think DOLs Fiduciary Rule Is Too Strict? Blame SEC

Gundlach Sounds Fed Alarm, Warns of Selloff Near Inauguration Day

This week, the U.S. Chamber of Commerce added to the welter of speculation over the Department of Labor’s fiduciary rule’s fate.

Chamber CEO Thomas Donohue said the organization is urging the incoming Trump administration’s transition team to undo the regulation. To date, the Trump administration hasn’t communicated its position on the rule.

Some firms have begun to release those changes along with education initiatives for advisors. Others have kept compliance efforts close to the vest for competitive purposes, said Larson.

But all will have to start releasing their intended course of action, and soon, in order to avoid the litigation and competition risks that will come from not being prepared for implementation.

Melissa Dimitri, a senior manager in Grant Thornton’s Advisory Services, which provides strategic consulting to financial services and insurance companies, says her team is not swayed by the back-and-forth speculation over the rule’s fate.

stock market today news: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin]

    China Advanced Constructn Mtrls Grp Inc (NASDAQ: CADC) shares shot up 225 percent to $7.15 after gaining 2.33 percent on Wednesday.

    Shares of Smart Global Holdings Inc (NASDAQ: SGH) got a boost, shooting up 29 percent to $36.98 after the company issued strong guidance. The company updated Q1 guidance, raising adjusted EPS from 79 cents-83 cents to 90 cents-93 cents. Sales guidance was raised from $225 million-$240 million to $250 million-$260 million.

stock market today news: Graham Corporation(GHM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Graham Corporation (NYSE: GHM) is expected to report its quarterly earnings at $0.12 per share on revenue of $23.54 million.

    Heico Corp (NYSE: HEI) is estimated to post its quarterly earnings at $0.54 per share.

stock market today news: Toll Brothers Inc.(TOL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market once again proved its resiliency on Wednesday, bouncing back from extensive declines early in the session to recover most of its losses. The Dow Jones Industrials actually managed to post yet another record close with a modest gain, and although other major market benchmarks suffered declines, they weren’t significant. Moreover, some favorable news from certain pockets of the market helped bolster investor confidence. Toll Brothers (NYSE:TOL), Lantheus Holdings (NASDAQ:LNTH), and Norwegian Cruise Line Holdings (NASDAQ:NCLH) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Jim Powell]

    Steve Halpern: You mentioned home builders and one that you’ve been bullish on is Toll Brothers (TOL). Do you still like that stock?

    Jim Powell: I certainly do. It’s in there for the long haul. They’ve made some really good strategic decisions. One of the trends that I’ve been following is the millennial generation and what their habits are and what their preferences are.

  • [By Lisa Levin]

    Toll Brothers Inc (NYSE: TOL) reported stronger-than-expected profit for its third quarter, while revenue missed estimates

    Toll Brothers posted quarterly earnings of $0.87 per share on revenue of $1.502 billion. However, analysts were expecting earnings of $0.69 per share on revenue of $1.51 billion.

  • [By WWW.THESTREET.COM]

    Next, on Tuesday, earnings from Darden Restaurants (DRI) and KB Home (KBH) . Cramer said he liked both companies, but prefers Toll Brothers (TOL) among the homebuilders.

  • [By Lisa Levin]

    Toll Brothers, Inc. (NYSE: TOL) reported downbeat results for its fourth quarter.

    Toll Brothers posted quarterly earnings of $1.17 per share on revenue of $2.03 billion. However, analysts expected earnings of $1.19 per share on revenue of $2.08 billion.

  • [By Eileen Rojas]

    Toll Brothers has rising sales volume and unit prices
    For the third quarter ended on July 31, Toll Brothers’ (NYSE: TOL  ) net income was $46.6 million, or $0.26 per share. The latest income figures were down 24% from last year’s third-quarter results of $61.6 million, or $0.36 per share. The company’s total quarterly revenues were $689.2 million, up 24% over last year, and homebuilding deliveries were 1,059 units, up 10% compared to the same period last year.

stock market today news: Mitsubishi UFJ Financial Group Inc(MTU)

Advisors’ Opinion:

  • [By Jim Jubak, Senior Markets Editor, MoneyShow.com]

    The one currency that is running against the weak dollar tide is the Japanese yen. The yen initially climbed on the Fed’s no taper decision—rising to 97.75 on the news—but then fell all the way back to 99 yen to the dollar and finished yesterday at 99.42. (Remember that since the yen is quoted in yen to the dollar, a higher number is a sign of a weak yen and a smaller number means the yen is getting stronger.) The thinking seems to be that the recent Japanese trade deficit will push the Bank of Japan to further weaken the yen, in order to boost Japanese exports. I continue to think that the yen will finish 2013 at weaker levels than current trading, and that leads me to continue to hold positions in Japanese stocks such as Toyota Motor (TM) and Mitsubishi UFJ Financial Group (MTU). Both stocks are members of my Jubaks Picks portfolio.

stock market today news: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Of course, Donald Trump took on the health care industry in his press conference today, so Gilead’s shares–and just about every other biotech and pharmaceutical company–are getting smacked down. Its stock fallen 2.4% to $25.03 at 3:30 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has fallen 2.9% to$278.49.

  • [By Ben Levisohn]

    Biotech stocks have been particularly unloved during the past year, with the iShares Nasdaq Biotech Index ETF (IBB) gaining just 7% to the S&P 500′s 20% rise. Today, however, Amgen (AMGN) is getting a lot of love from the market after releasing Street beating earnings and reporting that its anti-cholesterol drug reduced heart attacks.

  • [By WWW.THESTREET.COM]

    Biotechnology stocks had an incredible run between 2012 and 2015, and the iShares Nasdaq Biotechnology ETF (IBB) was up 395% in that time. After making the record high, however, the space came under pressure and the fund dropped below its 40-week moving average, eventually retracing 50% of its historic rally before finding support in the $240.00 area. Since that time, it has been moving in a horizontal channel below the 38% retracement level of the pullback range in the $300.00 area, and 2016 triple-bottom support.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By Kumar Abhishek]

    It has not been a good year for Gilead Sciences (NSDQ:GILD) shareholders. Gilead stock is down bymore than 25% YTD and almost 30% in last one year. The stock has not only heavily underperformed the broader marketbut has also lagged the sector index iShares NASDAQ Biotech Index ETF (NSDQ:IBB) which is down nearly 17% YTD.The poor performance of the stock is mainly caused by declining HCV sales numbers. HCV was the main growth driver for Gilead till a few quarters back. But the sales in this segment have seen aconsistent decline over the last few quarters which has lead to an increasingly bearish sentiment around the stock. Many analystsbelieve that the bearish sentiment is overdone, and the stock will rebound on strong fundamentals.

  • [By Ben Levisohn]

    Shares of Gilead Sciences have dipped 0.1% to $68.97 at 1:05 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $296.51.

Leave a Reply

Your email address will not be published. Required fields are marked *